The share price is irrelevant at the moment, if everything progresses as planned with phase2/3 (Cohart 4 10mg/kg study), we'll possibly see the SP around $2.0 at this time of July 2025 (some time things happens much faster similar to DXB). It is too early to claim anything before next read out, however if FDA approval announced by early 2026, the sky is the limit. The PAA holding goes at the bottom of the shelve but will be watching post in HC to understand investor sentiments.
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-735
-
- There are more pages in this discussion • 206 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $99.65M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $95.38K | 475.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 135256 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 79851 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |